Valuation: ConvaTec Group

Market Cap 602.04Cr 515.71Cr 482.54Cr 441.71Cr 828.96Cr 58TCr 839.91Cr 5.7TCr 2.22TCr 29TCr 2.26TCr 2.21TCr 96TCr P/E 2026 *
24.2x
P/E 2027 * 16.9x
Enterprise Value 736.64Cr 631Cr 590.41Cr 540.45Cr 1.01TCr 70TCr 1.03TCr 6.98TCr 2.72TCr 35TCr 2.77TCr 2.71TCr 1,17100Cr EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.62x
Free-Float
95.17%
Yield 2026 *
2.57%
Yield 2027 * 2.92%
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 601.52Cr
+2.19%+4.83%-11.93%+12.47% 20TCr
+1.14%+3.06%+0.14%+14.51% 12TCr
+1.06%+2.59%+4.73%+76.30% 6.01TCr
-1.37%-6.27%+28.79%+60.98% 5.32TCr
+2.33%+5.51%-3.61%-29.85% 5.11TCr
+2.35%+0.94%+13.06%-12.93% 3.4TCr
+5.16%-3.71% - - 2.86TCr
-0.20%+2.00%+43.31%-8.95% 2.49TCr
+0.93%+0.79%-4.66%+6.28% 2.3TCr
Average +1.36%-0.37%+8.73%+14.85% 6.56TCr
Weighted average by Cap. +1.54%+0.83%+1.26%+17.72%

Financials

2026 *2027 *
Net sales 255.63Cr 218.97Cr 204.88Cr 187.55Cr 351.97Cr 24TCr 356.62Cr 2.42TCr 943.97Cr 12TCr 959.85Cr 938.96Cr 41TCr 273.18Cr 234Cr 218.95Cr 200.42Cr 376.14Cr 26TCr 381.11Cr 2.59TCr 1.01TCr 13TCr 1.03TCr 1TCr 43TCr
Net income 25Cr 21Cr 20Cr 18Cr 34Cr 2.38TCr 35Cr 235.08Cr 92Cr 1.19TCr 93Cr 91Cr 3.95TCr 36Cr 31Cr 29Cr 26Cr 50Cr 3.44TCr 50Cr 340.94Cr 132.95Cr 1.73TCr 135.19Cr 132.25Cr 5.72TCr
Net Debt 134.59Cr 115.29Cr 107.88Cr 99Cr 185.32Cr 13TCr 187.77Cr 1.27TCr 497.02Cr 6.47TCr 505.38Cr 494.39Cr 21TCr 114.73Cr 98Cr 92Cr 84Cr 157.98Cr 11TCr 160.06Cr 1.09TCr 423.69Cr 5.51TCr 430.81Cr 421.44Cr 18TCr
Logo ConvaTec Group
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA